December 11, 2024 - 00:43

In a significant development, Mike Jeffries, the former CEO of Abercrombie and Fitch, has requested a hearing to assess his mental fitness to stand trial on serious sex trafficking charges. This legal maneuver is expected to delay proceedings in a case that has garnered considerable public attention due to the nature of the allegations.
Jeffries is accused of orchestrating an international sex trafficking operation, involving numerous victims and extensive networks. The charges against him paint a troubling picture of exploitation and abuse, raising questions about the accountability of powerful figures in the fashion industry.
The outcome of the mental fitness hearing could have profound implications for the trial, potentially impacting both the timeline and the legal strategies employed by Jeffries' defense team. As the case unfolds, it is likely to shine a spotlight on broader issues of consent, power dynamics, and the responsibilities of corporate leaders. The legal community and the public alike are watching closely as this high-profile case develops.
July 30, 2026 - 19:06
Medtronic leads $37M investment in CoreMap’s AFib mapping techMedical device giant Medtronic has taken the lead in a $37 million funding round for CoreMap, a company developing advanced mapping technology for atrial fibrillation. The investment signals a...
July 30, 2026 - 08:19
Live shopping startup Whatnot eyes massive $20 billion valuationWhatnot, the live shopping platform known for its fast-paced auctions and collector-focused marketplace, is reportedly in discussions to raise funds at a valuation of roughly $20 billion. That...
July 29, 2026 - 22:39
Hims misled consumers and violated their privacy, FTC alleges in a lawsuitThe U.S. Federal Trade Commission has filed a lawsuit against the popular telehealth company Hims & Hers, alleging that the firm misled consumers and mishandled their private health information....
July 29, 2026 - 03:21
Medtronic recalls thousands of cannulae due to risk of leaksMedtronic has initiated a recall affecting more than 50,000 cannulae after identifying a risk of pinhole leaks in the devices. The company announced the action following reports that these tiny...